drugset / Trial / NCT00485394

The OMEGA Study: Use of Eye Drops to Treat Geographic Atrophy Associated With Age-Related Macular Degeneration (Dry AMD)

NCT00485394 ↗

Phase 2 Unknown 198 enrolled Othera Pharmaceuticals
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this trial is to compare the ability of two doses of OT-551 ophthalmic solution and drug-free solution to safely and effectively treat geographic atrophy associated with age-related macular degeneration.

Timeline

Start
2007-06
Primary completion
2010-02
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject OT-551 Small molecule 0.3 % Topical
Subject OT-551 Small molecule 0.45 % Topical